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Aloe vera, a common ingredient in cosmetics, is increasingly being consumed as a beverage supplement. Although consumer
interest in aloe likely stems from its association with several health benefits, a concern has also been raised by a National Toxicology
Program Report that a nondecolorized whole leaf aloe vera extract taken internally by rats was associated with intestinal mucosal
hyperplasia and ultimately malignancy. We tested a decolorized whole leaf (DCWL) aloe vera, treated with activated charcoal to
remove the latex portion of the plant, for genotoxicity in bacteria, acute/subacute toxicity in B6C3F1 mice, and subchronic toxicity
in F344 rats. We found this DCWL aloe vera juice to be nongenotoxic in histidine reversion and DNA repair assays. Following acute
administration, mice exhibited no adverse signs at 3- or 14-day evaluation periods. When fed to male and female F344 rats over 13
weeks, DCWL aloe led to no toxicity as assessed by behavior, stools, weight gain, feed consumption, organ weights, and hematologic
or clinical chemistry profiles. These rats had intestinal mucosal morphologies—examined grossly and microscopically—that were
similar to controls. Our studies show that oral administration of this DCWL aloe juice has a different toxicology profile than that
of the untreated aloe juice at exposures up to 13 weeks.

1. Introduction
Aloe vera is a common ingredient in cosmetics, skin care
products, and increasingly, beverages and food products [1].
Recent consumer interest in aloe beverages may stem from
the association of aloe juice with a variety of both anecdotal and experimental research-supported health benefits
including the prevention or treatment of various tumors
[2, 3], arthritis [4], diabetes [5], enhanced immunity [6], and
decreased cholesterol levels [7].
Aloe juice is approximately 99% water [8] and the remainder consists of minerals, vitamins, polysaccharides, lipids,

phenolic compounds, and organic acids. According to the
International Aloe Scientific Council, the aloe leaf can be
processed into two types of juices for commercial use: inner
leaf gel juice and decolorized whole leaf juice [9]. Inner leaf
gel juice is produced from only the gelatinous fillet of the
leaf. Decolorized whole leaf juice is produced by grinding the
leaf followed by treatment of extracted juice with activated
charcoal to remove aloe “latex” [10]. Charcoal treatment is
necessary since the latex, which exists as a separate liquid
between the outer rind and inner fillet gel, contains bitter
phenolic molecules including anthraquinone C- and Oglycosides, anthrones, and some free anthraquinones [11].
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The major C-glycoside, aloin A, is the major anthraquinone
in aloe latex and when oxidized, yields aloe-emodin, a
free anthraquinone [11]. Anthraquinones are associated with
diarrhea in vivo [12, 13], weight loss, gall bladder lesions,
renal tubule pigmentation, and renal tubule hyaline droplets
[14]. In vitro, anthraquinones cause mutations in mouse
lymphoma [15] and salmonella assays [16]. Aloe beverages,
which follow IASC standards contain less than 10 ppm aloin
A and its isomer, aloin B [9].
Toxicology of various aloe products has been examined in
vivo, and these studies collectively suggest that the potential
for toxicity depends on the plant sections used in juice
production. Oral consumption of an ethanol extract of whole
leaf aloe over 3 months by mice resulted in reproductive
toxicity and increased mortality [17]. However, subchronic
administration of aloe taken from the inner leaf gel resulted
in no evidence of oral toxicity to rats [18]. In 2010, the
National Toxicology Program [10] released a technical report
on aloe vera that concluded that “there was clear evidence of
carcinogenic activity of a nondecolorized whole leaf extract
of Aloe vera in male and female F344/N rats based upon
increased incidences of adenomas and carcinomas of the
large intestine.” The results of this report have been referred
to on various health-related websites suggesting caution in
consumption of aloe products [19–22] and have generated
substantial interest and concern by aloe producers, because
the study results were based on a nondecolorized whole leaf
extract that is not commercially available [23]. The NTP study
was designed to deliver nondecolorized whole leaf, freezedried juice powder to test animals through their drinking
water at levels up to 3.0% (wt/wt), and the study examined
potential toxicologic effects of aloe in both B6C3F1 mice and
F344 rats over time periods of 14 days, 13 weeks, and 2 years
[10].
While an increased incidence of tumorigenesis was
observed in the large intestine of rats in the 2-year study,
no lesions were observed in mice or rats in acute studies;
however, there was decreased water consumption in both
rodent species at the highest aloe levels. During a subchronic
period (13 weeks), mice administered aloe were similar to
controls in most parameters with the exception of increased
incidences of mucosal hyperplasia with goblet cell hyperplasia in the cecum and large intestine. This mucosal and
goblet cell hyperplasia was also observed in rats at 13 weeks.
These rats displayed increased mortalities and weight losses
at the high aloe concentrations. Rats exposed for two years
also were found to have mucosal hyperplasia in the colon,
particularly in the cecum and ascending portions. Large
intestine mucosal/goblet cell hyperplasias were also observed
in mice exposed for two years; however, these mice did not
show increased neoplasms and had similar survival and body
weights as control groups.
The nondecolorized whole leaf powder used by the NTP
contained the bitter latex of the aloe plant and therefore,
the addition of this aloe directly to drinking water could
have contributed to the study’s outcomes. Palatability can
influence water consumption and conceivably could have also
contributed to the weight loss and mortality in the two-year
study. Commercial aloe beverages that contain little or no

Journal of Toxicology
latex anthraquinones may have yielded different outcomes
in the subchronic or chronic exposure tests. The NTP also
assessed the acute effects of aloe gel only and decolorized
(activated charcoal treated) whole leaf aloe, and in these studies, mice and rat body weights, water and feed consumptions,
organ weights, hematology, clinical chemistry, and urine
chemistry were generally similar to controls. However, only
the nondecolorized extract was used in the 13-week and 2year studies.
Although the reported incidence of large intestinal
tumors has garnered the most attention from the NTP report,
the incidences of intestinal mucosal hyperplasia were the
most consistent observations across species exposed both
subchronically and chronically. This mucosal hyperplasia
suggests a toxicological response to one or more whole
leaf aloe components. In the rat, hyperplasia of both the
mucosa and goblet cells may indicate cellular damage and
could be prognostic of later tumor development since control
rats showed little or no hyperplasia at 13 weeks or adenoma/carcinomas of the large intestine at 2 years.
To date, no evaluation of the de-colorized whole leaf Aloe
vera juice has been reported. In the present study, we report
the first toxicological evaluation of a commercially available,
decolorized, whole leaf (DCWL) Aloe vera beverage, Lily of
the Desert Filtered Whole Leaf Aloe vera Juice. This particular product can be considered as being well characterized with
regard to high-molecular-weight polysaccharide content [24]
and immunomodulating activity [25, 26]. Testing included
assessment of potential genotoxicity in vitro and acute toxicity
in vivo using a B6C3F1 mouse model. Further testing included
a 13-week study utilizing F344 rats in which the DCWL
juice was administered through the rat’s chow in order
to impart a minimal effect on palatability. Examinations
included large intestinal histology to understand if aloe
beverages derived from DCWL aloe vera juice produced
toxicologic signs associated with nondecolorized whole leaf
juice.

2. Materials and Methods
2.1. Procurement of DCWL Aloe Vera Juice. Aloe vera leaves
were harvested and maintained under cold storage (8∘ C) until
processing. Time lapse from harvest to processing was less
than six hours. The harvested leaves were washed, disinfected, and macerated to yield an intermediate raw material
representative of a nondecolorized whole leaf extract as was
used in the aforementioned NTP study. The nondecolorized
extract was then filtered using carbon/diatomaceous earth to
yield a DCWL extract. To this extract, a proprietary isolate
of high-molecular-weight aloe vera polysaccharide, Aloesorb,
was added at a rate of 30 mg solid/fluid ounce. The resulting
extract was flash-pasteurized to yield the commercial product
(Lily of the Desert Filtered Whole Leaf Aloe vera Juice with
Aloesorb). This product was vacuum-dried to yield a 7-fold
concentrate.
NMR analysis of the resulting extract established (1)
the presence of Aloe vera (by confirming the presence of
aloe vera polysaccharide, malic acid, and glucose), (2) the
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presence of whole leaf markers (isocitrate and isocitratelactone), and (3) the absence of adulterants/stabilizers in the
extract. HPLC analysis confirmed the presence of low levels of
anthraquinones (Aloin A at 0.868 ppm, Aloin B at 1.335 ppm,
and Aloe-emodin at 0.200 ppm). These results qualify the
extract as a decolorized whole leaf aloe vera extract.
The juice was maintained under constant refrigeration
until use. Prior to testing, the aloe juice was lyophilized and
determined to be 10.65 ± 0.11% nonaqueous. It was also
found to be acidic (pH = 3.9). Prior to analysis in genotoxicity assays, the aloe juice was filtered using positive pressure
to render it sterile and the pH adjusted to 7.5 to accommodate
Salmonella bacterial assays that are pH-sensitive. In order
to maximize the level of aloe administered to test mice, the
7x juice was further concentrated by lyophilization to a final
concentration of 35x in a Labconco lyophilizer over a 6-hour
period. This concentrated juice was administered in gavage
studies. A single lot (#021412-4) was used throughout the
studies.
2.2. Genotoxicity Assays. Potential mutagenicity and/or DNA
damage were assessed in vitro with two bacterial assays.
An assay for mutagenesis was used, which is based on the
Ames test utilizing Salmonella typhimurium strain TA100 but
modified for liquid culture and a 96-well plate scale. The
second assay detected potential DNA damage utilizing an
E. coli strain containing a transgene for beta-galactosidase
downstream of the SOS-DNA repair promoter system. Both
assays were purchased in a commercial format from EBPI
Bio-Detection Products (Mississauga, ON, Canada), referred
to the as Muta-Chromo Plate and SOS-Chromo Test Assays,
respectively.
To test for potential metabolic generation of mutagens,
DCWL aloe vera juice was also tested in the presence of
S9 liver extract. For testing with Salmonella, the juice was
combined with a reaction mix containing growth substances
and a pH indictor. The juice was administered at 21x, 14x,
and 7x concentrations. As a positive control for direct acting
mutagenesis (i.e., independent of metabolic conversion),
either sodium azide (0.38 𝜇M final concentration) or 2nitrofluorene (7.1 𝜇M final concentration) was included in
one plate. 2-Aminoanthracene (2.60 𝜇M final concentration)
was used as a positive control for mutagenesis requiring
metabolism. Plates containing no aloe juice were used to
measure spontaneous mutations over the incubation periods,
and these blanks were compared to all aloe-containing plates.
The number of positive mutated wells was scored on days
3, 4, and 5 of growth. These numbers were then compared
statistically to blanks.
For the DNA damage assay in E. coli, the DCWL
juice was tested at levels of 21x, 14x, 7x, 3.5x, 1.75x, 0.88x,
0.44x, 0.22x, 0.11x, and 0.055x. When diluted, the juice was
suspended in sterile 10% dimethyl sulfoxide (DMSO) in
sterile 0.85% saline. A positive control for DNA damage
independent of metabolism was included (4-nitroquinoline
oxide [4NQO]) and used at levels of 10.0 𝜇g/mL (52.6 𝜇M),
5.0, 2.5, 1.25, 0.625, and 0.3125 𝜇g/mL. A positive control for
mutagenesis requiring metabolism was included in another

3
plate (2-aminoanthracene) and used at 100.0 (2.6 𝜇M), 50.0,
25.0, 12.5, 6.25, and 3.125 𝜇g/mL. DNA damage was quantitated spectrophotometrically by color development. Data are
expressed as the mean and standard deviation of the SOS
induction.
2.3. Animals. All mice were purchased from Jackson Laboratories, Inc. and were ordered between 4 and 6 weeks of
age. After a two-week period of quarantine, the mice were
numbered for identification by ear tag. Upon initiation of
studies, mice were weighed, sorted into boxes of 5 mice each,
and then randomly assigned to control or aloe juice groups.
Mice were housed within the Louisiana State University Division of Laboratory Medicine’s AALAC-approved vivarium in
Super Mouse Micro Isolation 750 boxes that are racked in an
Enviro-Gard-B microisolation control cage rack (Lab Products, Seaford, DE). Cage changes with fresh litter and fresh
water were provided weekly to the mice. Mouse boxes were
stocked with clean/autoclaved Bio-Serv (Frenchtown, N.J.)
mouse Igloo and Fast-Trac spinning enrichment devices and
Nestlets pads (Ancare, Bellmore, NY). All animal procedures
followed the National Research Council’s “GUIDE FOR THE
CARE AND USE OF LABORATORY ANIMALS” and were
first reviewed and approved by the LSU IACUC.
F344 rats were purchased from Charles River Laboratories and arrived at 7 weeks of age. After a two-week period
of quarantine, rats were identified by permanent marker on
the tail. The rats were individually housed. Cage boxes were
changed with fresh litter and fresh water weekly, and boxes
were stocked with clean/autoclaved Crawl Balls enrichment
devices (Bio-Serv, Frenchtown, N.J.).
2.4. Toxicity at 3- and 14-Day Time Periods in Mice. DCWL
aloe juice was administered by gavage with a 20-gauge curved
stainless steel gavage needle (Popper & Sons, New Hyde Park,
NY) to male and female B6C3F1 mice twice over a 24-hour
period at 1.0% of body weight. Seven mice per test group were
gavaged either concentrated juice or water then observed
daily for abnormal behaviors including hypoactivity, isolation
from littermates, ataxia, dyspnea, or prostration. In addition,
mice were monitored for a weight loss of 10% or greater,
decreased feed consumption of 10% or greater, and death.
Through the oral gavage, female mice consumed an
estimated amount of aloe vera juice equal to 32.1 times
the amount a person would normally drink per 24-hour
period. Male mice consumed an average of 27.8 times this
amount. These estimates were determined by assuming the
recommended daily amount of aloe juice a person drinks to
be 8.0 ounces (236.6 mL). To scale this quantity to a mouse,
we used body surface area ratio [27] comparing mice groups
with a 5 feet, 10 inches person weighing 70 kg.
At the conclusion of the 3- and 14-day periods, gross
necropsies were performed on all animals, and final body
weights plus weights of the kidney (right), heart, lung, liver,
and testes (males) were recorded. Hematologic parameters
were assessed on blood samples collected in potassium
EDTA containers. This analysis included RBC, Hb, HCT,
RDW, MCV, MCH, MCHC, platelets, MPV, and total WBCs.
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Liver sections were screened independently by two pathologists. Finding of pathologic anomalies would trigger further
microscopic evaluation of all organs collected from mice.
Body weight, organ weights and all hematologic and clinical
chemistry parameters were analyzed within each sex by
Student’s t-test, with significance as 𝑃 ≤ 0.05.
2.5. Subchronic Toxicity in F344 Rats. Rats were divided into
groups of 6 or 7. Control groups received AIM-93G chow
(Teklab, Madison, WI) ad libitum while aloe-treated rats
consumed chow formulated with concentrated aloe juice in
place of water (Teklab, Madison, WI) for 13 weeks. Each week,
weights of individual rats and feed consumed were recorded.
Animals were assessed daily for general behavior, health, and
appearance as well as appearance of stools.
At the conclusion of the 13-week study period, rats were
anesthetized with isoflurane for blood collection and then
humanely euthanized. At necropsy, general body appearance
and external orifices were examined prior to examination
of internal organs. Abdominal, pelvic, and thoracic organs
were observed in situ, then the liver, kidneys, testes (in
males), heart, and lungs were removed, weighed, rinsed
with phosphate-buffered saline (PBS), and placed into 10%
neutral buffered formalin (NBF). The intestinal tract was
examined from the stomach distally, and then the tract
from the cecum distally was labeled using colored thread
for cecum, ascending, transverse, and descending colon and
rectum. The large intestines were then removed, placed in
PBS, and sectioned according to anatomic region. Intestinal
contents were gently flushed with PBS, and using a blunt
needle, the cecum was opened along the greater curvature
and flushed and examined for gross lesions. The cecalcolic junction was opened and grossly examined. Each large
intestinal region was preserved in 10% NBF. The small
intestine was opened and grossly examined and preserved
if lesions were observed. Fixed tissues were embedded in
paraffin and sectioned at 7 um onto glass slides and stained
with hematoxylin and eosin. Histological preparations and
microscopic evaluations were made of the liver, cecum,
and colon tissues (ascending, transverse, descending) and
rectum. Each large intestine anatomic region was evaluated
and scored using a semiquantitative scale in increments of 0.1
in which 0–0.9 indicated hypoplastic mucosa, 1.0–1.9 indicated mucosal architecture and cellular populations within
expected ranges, 2.0–2.9 indicated moderate hyperplasia of
the mucosal epithelia and increased lymphocytic infiltrate
and/or goblet cell hyperplasia and secretion, and 3.0–3.9
indicated pronounced hyperplasia of mucosa and goblet cells,
lymphoid aggregates with enlarged germinal centers, and
inflammatory infiltrate. Mucosa of rats was independently
scored by three reviewers, and the average scores for each
large intestinal region were computed for aloe treatment and
controls of each sex.
Feed consumption and body weight changes during
the 13-week period were compared using two-way repeated
measures ANOVA with Bonferroni post-tests. Organ weights
were compared using an unpaired t-test with significance
set a 𝑃 ≤ 0.05. Hematologic tests included RBC, Hgb,
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HCT, RDW, MCV, MCH, MCHC, platelets, MPV, plasma
protein, PCV, WBCs, neutrophils, lymphocytes, monocytes,
and eosinophils. Clinical chemistry assays included glucose,
AST, ALT, ALP, CK, T protein, albumin, globulin, cholesterol,
BUN, creatinine, calcium, phosphorus, sodium, potassium,
chloride, bicarbonate, and anion gap. Samples were compared
with gender-matched controls using an unpaired t-test (𝑃 ≤
0.05). Large intestinal mucosal thickness scores were compared using Mann-Whitney U ranking to obtain a P value set
as 𝑃 ≤ 0.05.
2.6. Verification of Aloe Juice Level in Feed. To verify DCWL
aloe juice levels in the compounded feed, one juice constituent, malic acid, was determined in samples of 9.3x
concentrated juice prior to compounding and in samples of
the final aloe-containing chow. A Malate Assay kit (Biovision,
Milpitas, California) was used to measure L(-) malate. The
9.3x aloe juice contained a measured 362.0 ± 18.0 mM malate;
therefore, the chow was expected to contain a malate of
36.2 mM. The final measured malate concentration extracted
from the finished chow was 37.8 ± 1.29 mM, or 104.4 ± 3.4%
of the expected.
Male rats in this study consumed an average of 14.3 g
aloe chow/day or 540.5 𝜇mol malate/day. Female rats consumed an average of 9.13 g of aloe chow/day or 344.0 𝜇mol
malate/day. These malate levels indicate that the male rats
exceeded a recommended 8.0 ounce human consumption by
5.9-fold and the female rats exceeded the human consumption of aloe juice by 5.1-fold based on body surface area.

3. Results
3.1. Genotoxicity. DCWL aloe vera juice extract when tested
at up to a 21x concentration was not significantly mutagenic
to test Salmonella spp. bacteria in the absence or presence
of S9 liver extract. The blank plate without S9 showed a
similar number of revertant wells in aloe plates of 21x, 14x,
or 7x (Table 1(a)). Similarly, the blank plate with S9 did not
show any significant differences from revertant wells in aloe
+S9 plates of 21x, 14x, or 7x (Table 1(b)). The P value was
≥0.05 for all aloe juice concentrations, without and with
S9. These statistics applied to both the TA100 and TA98
strains. This mutagenicity assay was developed sufficiently
to be interpreted between days 3 and 5. A bacteria-free
plate remained without growth indicating that there was no
external bacterial contamination in the assay and positive
controls for both sodium azide and 2-aminoanthracene plus
S9 extract verified assay function (data not shown).
SOS DNA repair in E. coli was not activated by
DCWL aloe vera juice extract in concentrations ranging
from 21-fold concentrated to approximately 20-fold diluted
(Figure 1(a)). The juice product also did not show significant concentration-related DNA damage/repair in the
presence of metabolically active liver extract (Figure 1(b)).
These data indicate that juice does not contain significant levels of active or latent genotoxic compounds. SOS
DNA repair was activated in the positive control 4-nitroquinoline oxide (4NQO) resulting in a concentration-
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Table 1: (a) Effects of aloe juice on S. typhimurium TA100 mutagenesis, (b) Effects of aloe juice on S. typhimurium TA98 mutagenesis.
(a)

Sample
Blank without S9
Blank + S9
WL Aloe 21x
WL Aloe 21x + S9
WL Aloe 14x
WL Aloe 14x + S9
WL Aloe 7x
WL Aloe 7x + S9
WL Aloe 7x + 2x S9

No. of positive wells
@ 2 days
0
0
0
0
0
0
0
0
0

No. of positive wells
@ 3 days
3
3
0
2
0
0
2
0
2

No. of positive wells
@ 4 days
3
11
0
0
0
0
4
1
3

No. of positive wells
@ 5 days
5
16
0
0
0
10
9
6
8

No. of positive wells
@ 4 days
1
17
0
15
2
14
0
3
10

No. of positive wells
@ 5 days
2
20
3
17
4
16
0
11
15

@ indicates at.
(b)

Sample
Blank without S9
Blank + S9
WL Aloe 21x
WL Aloe 21x + S9
WL Aloe 14x
WL Aloe 14x + S9
WL Aloe 7x
WL Aloe 7x + S9
WL Aloe 7x + 2x S9

No. of positive wells
@ 2 days
0
0
0
0
0
0
0
0
0

No. of positive wells
@ 3 days
0
3
0
0
0
0
0
0
0

Mutagenicity of aloe juice

0.6

0.4

0.2

Abs 615 nm

Abs 615 nm

0.4
0
−0.2
−0.4
−0.6
−0.8

Mutagenicity of aloe juice +S9

0.6

0.2
0
−0.2
−0.4
−0.6

0.01

10
0.1
1
Fold concentration of aloe juice

−0.8

100

0.01

(a)
0.3

Mutagenicity of 4NQO

Mutagenicity of 2-AA +S9

0.3
0.25

0.2

Abs 615 nm

Abs 615 nm

100

(b)

0.25
0.15
0.1
0.05
0
100

0.1
10
1
Fold concentration of aloe juice

0.2
0.15
0.1
0.05

1000
4NQO concentration (ng/mL)

10000

(c)

0

100

1000
2-AA concentration (𝜇g/mL)

10000

(d)

Figure 1: Effects of DCWL aloe vera juice on DNA damage repair. Absorbance reflects measurement of SOS transgene (𝛽-galactosidase)
induction and subsequent substrate conversion. Symbols represent means of triplicate wells incubated in the absence or presence of S9 rat
liver extract. Error bars represent standard deviations.

dependent increase in DNA repair gene activity (Figure 1(c)).
Bacteria also showed a concentration-dependent increase
in DNA damage repair gene activity when exposed to

the positive control chemical 2-aminoanthracene (2-AA) in
the presence of metabolic extract from rat liver (Figure
1(d)).
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Table 2: Selected organ weights of B6C3F1 mice administered aloe juice by gavage.

3 days post aloe
Mortalities
Abnormal clinical signs
Gross abnormalities
Weight change % init. b.wt.
Relative organ weight∧
Liver relative weight
Kidney (rt)
Heart
Lung
Testicle (rt)
14 days post aloe
Mortalities
Abnormal clinical signs
Gross abnormalities
Weight Change % init. b.wt.
Relative organ weight∧
Liver
Kidney (rt)
Heart
Lung
Testicle (rt)

Male control
0/6
0/6
0/6
0.115 ± 1.03

Aloe male
0/6
0/6
0/6
0.868 ± 2.15

Control female
0/6
0/6
0/6
4.12 ± 2.83

Aloe female
0/6
0/6
0/6
3.87 ± 2.05

4.58 ± 0.240
0.769 ± 0.072
0.460 ± 0.046
0.592 ± 0.088
0.390 ± 0.044

4.35 ± 0.113
0.750 ± 0.029
0.473 ± 0.044
0.578 ± 0.062
0.371 ± 0.017

5.01 ± 0.173
0.724 ± 0.047
0.480 ± 0.025
0.667 ± 0.033
—

4.97 ± 0.315
0.679 ± 0.048
0.498 ± 0.056
0.663 ± 0.069
—

0/6
0/6
0/6
3.36 ± 2.91

0/6
0/6
0/6
6.37 ± 0.772

0/6
0/6
0/6
7.18 ± 2.65

0/6
0/6
0/6
6.85 ± 3.46

4.85 ± 0.252
0.769 ± 0.072
0.487 ± 0.077
0.633 ± 0.080
0.390 ± 0.044

4.65 ± 0.108
0.750 ± 0.029
0.442 ± 0.037
0.614 ± 0.650
0.371 ± 0.017

5.21 ± 0.372
0.724 ± 0.047
0.585 ± 0.063
0.725 ± 0.075
—

4.74 ± 0.388
0.679 ± 0.048
0.482 ± 0.061
0.662 ± 0.053
—

Values presented as mean ± s.d.
∧
Relative organ weights are expressed as a percent of body weight.

Table 3: Hematology of whole blood from B6C3F1 mice administered aloe juice by gavage.
Parameters—3 days post exposure
RBC (106 /uL)
Hb (g/dL)
HCT (%)
RDW (%)
MCV (fL)
MCH (fL)
MCHC (g/dL)
Platelets (103 /uL)
WBC’s (103 /uL)
Parameters—14 days post exposure
RBC (106 /uL)
Hb (g/dL)
HCT (%)
RDW (%)
MCV (fL)
MCH (fL)
MCHC (g/dL)
Platelets (103 /uL)
WBC’s (103 /uL)

Control male
8.6 ± 0.21
13.1 ± 0.33
43.5 ± 1.29
12.7 ± 0.45
50.4 ± 0.48
15.2 ± 0.04
30.1 ± 0.23
1100.0 ± 102.10
2.2 ± 1.02

Aloe male
8.8 ± 0.18
13.4 ± 0.28
44.1 ± 1.16
12.7 ± 0.30
50.2 ± 0.86
15.3 ± 0.18
30.4 ± 0.32
1116.8 ± 129.31
3.3 ± 2.86

Control female
8.7 ± 0.26
13.3 ± 0.33
43.2 ± 1.34
12.3 ± 0.46
49.6 ± 0.30
15.4 ± 0.18
31.0 ± 0.43
952.2 ± 128.94
2.1 ± 0.92

Aloe female
8.8 ± 0.25
13.4 ± 0.31
42.9 ± 1.21
11.9 ± 0.36
48.7 ± 0.44∗
15.2 ± 0.16
31.2 ± 0.27∗
1041.7 ± 128.75
2.3 ± 0.58

8.7 ± 0.32
13.2 ± 0.39
44.7 ± 2.03
13.0 ± 0.43
51.0 ± 0.75
15.1 ± 0.18
29.5 ± 0.50
1068.8 ± 129.2
4.2 ± 1.5

8.7 ± 0.27
13.1 ± 0.41
43.8 ± 1.21
13.2 ± 0.64
50.2 ± 0.45∗
15.0 ± 0.08
29.8 ± 0.36
1100.0 ± 104.5
3.8 ± 1.1

8.4 ± 0.28
13.1 ± 0.64
42.7 ± 0.87
14.0 ± 3.53
51.7 ± 3.54
15.8 ± 0.19
30.6 ± 1.6
955.2 ± 310.53
3.1 ± 2.3

8.7 ± 0.35
13.6 ± 0.42
43.3 ± 1.48
12.2 ± 0.71
49.6 ± 0.28
15.6 ± 0.14
31.5 ± 0.14
1023.5 ± 16.2
2.4 ± 0.42

Values expressed as mean ± s.d.
∗
𝑃 ≤ 0.05.
RBC: red blood cell count; Hb: hemoglobin; HCT: hematocrit; MCV: mean corpuscular volume; MCH: mean corpuscular hemoglobin; WBC: total white blood
cell count; RDW: red blood cell distribution width; MCHC: mean corpuscular hemoglobin concentration; WBC’s: white blood cell count.

3.2. Effects of Acute DCWL Aloe Administration in Mice
at 3 and 14 Days Postadministration. There were no mortalities in any mice fed high concentrations of aloe juice.
Mice were equivalent to control mice in behavior. Male

and female mice after both 3 and 14 days postadministration of aloe had body and organ weights similar to
control mice (Table 2). Necropsy was unremarkable in all
mice.
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Table 4: Clinical chemistry of plasma from B6C3F1 mice administered aloe juice by gavage.
Parameters—3 days post exposure
ALT (U/L)
ALP (U/L)
CK (U/L)
TBIL (mg/dL)
Total protein
BUN (mg/dL)
Creatinine (mg/dL)
Parameters—14 days post exposure
ALT (U/L)
ALP (U/L)
CK (U/L)
TBIL (mg/dL)
Total protein
BUN (mg/dL)
Creatinine (mg/dL)

Control male
26.0 ± 3.5
64.2 ± 4.4
287.6 ± 264.8
≤0.1#
4.5 ± 0.23
18.0 ± 1.2
≤0.2#

Aloe male
23.0 ± 5.4
60.56 ± 7.3
146.0 ± 114.7
≤0.1
4.3 ± 0.1∗
18.0 ± 1.4
≤0.2

Control female
18.4 ± 2.0
87.8 ± 9.4
85.4 ± 29.2
≤0.1
4.1 ± 0.13
22.8 ± 1.9
≤0.2

Aloe female
19.7 ± 2.2
88.8 ± 16.4
120.2 ± 68.3
≤0.1
4.0 ± 0.42
22.5 ± 1.1
≤0.2

25.2 ± 7.4
71.2 ± 18.0
117.0 ± 14.3
≤0.1#
3.8 ± 0.06
20.8 ± 4.0
≤0.2#

21.8 ± 6.5
67.4 ± 5.0
169.2 ± 86.9
≤0.1
4.0 ± 0.3
21.8 ± 2.6
≤0.2

23.2 ± 11.9
101.3 ± 3.9
157.2 ± 105.5
≤0.1
3.8 ± 0.03
24.3 ± 2.3
≤0.2

18.7 ± 2.4
86.2 ± 16.6
196.0 ± 144.6
≤0.1
3.8 ± 0.2
22.2 ± 1.0
≤0.2

Values expressed as mean ± s.d.
∗
𝑃 ≤ 0.05.
ALT: alanine aminotransferase activity; ALP: alkaline phosphatase Activity; CK: creatine kinase; TBIL: total bilirubin; BUN: blood urea nitrogen.
#
Levels for TBIL and creatinine were at or below instrument quantitation threshold.
25
Daily feed consumptions
(grams)

Weight (grams)

500

400
300
200
100
0

20
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0
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Days of age
Female aloe rat weight
Female control rat weight

Male aloe rat weight
Male control rat weight

77 84 91 98 105 112 119 126 133 140 147 154 161
Days of age
Female aloe rat feed
Female control rat feed

Male aloe rat feed
Male control rat feed

Figure 2: Weekly body weights of male and female rats fed DCWL
aloe vera diet over 13 weeks. The symbols represent mean values for
control and aloe-fed groups error bars show standard deviations.

Figure 3: Weekly feed consumption of male and female rats fed
DCWL aloe vera diet over 13 weeks. The symbols represent mean
values for control and aloe-fed groups error bars show standard
deviations.

Hematologic values from blood sampled from mice at 3
days and 14 days postexposure to the aloe vera juice were
generally similar to control group mice (Table 3). The few
values that appeared to be different between groups had
very small variances within groups; thus, small differences
between means were statistically calculated as different.
However, in all cases the differences between means were 10%
or less. Clinical chemistry values from blood sampled at these
time periods were also similar to values for control group
mice (Table 4).
Sections of liver from aloe-gavaged and control mice were
microscopically examined. The architecture of the tissues
and cellular morphology were considered typical of mice at
their age (data not shown). For instance, male livers from

both control and mice treated with the test extract showed
moderate cytoplasmic vacuolation, instances of binucleate
hepatocytes, and extramedullary hematopoiesis (EMH). The
female mice treated with the test extract as well as controls
showed multifocal EMH, some cytoplasmic vacuolation, and
binucleate hepatocytes, but did not display the occasional
mild hepatocellular necrosis seen in males. No pathologic
features were determined to be exclusively or predominantly
associated with test groups.
3.3. Subchronic Feed Administration, 13-Week Rat Studies.
During the course of study, there were no mortalities in
any group. DCWL aloe vera-fed rats were equivalent to
control rats in behavior. Both body weight gains and feed
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Table 5: The effect of aloe vera administration for 13 weeks on rat organ weights.
Parameter
Mortalities
Abnormal clinical signs
Gross abnormalities at necropsy
% body weight change
Relative organ weight∧
Liver
Kidney (rt)
Kidney (lf)
Heart
Lung

Male control
0/7
0/7
0/7
190.3 ± 6.63

WL aloe male
0/7
0/7
0/7
177.5 ± 23.10

Control female
0/6
1/6
0/6
143.6 ± 5.82

WL aloe female 13 week
0/7
0/7
0/7
144.4 ± 10.74

3.76 ± 0.233
0.338 ± 0.059
0.334 ± 0.077
0.325 ± 0.034
0.490 ± 0.081

3.82 ± 0.178
0.374 ± 0.070
0.412 ± 0.098
0.294 ± 0.050
0.550 ± 0.080

3.30 ± 0.103
0.334 ± 0.045
0.352 ± 0.049
0.419 ± 0.051
0.540 ± 0.059

3.28 ± 0.164
0.328 ± 0.072
0.336 ± 0.061
0.376 ± 0.044
0.497 ± 0.082

All values expressed as mean ± standard deviation.
∗
𝑃 ≤ 0.05 compared with gender control.
∧
Relative organ weights are expressed as a percent of body weight.

Table 6: The effect of aloe vera administration for 13 weeks on rat hematologies.
Parameter
RBC (106 /uL)
Hgb (g/dL)
HCT (%)
RDW (%)
MCV (fL)
MCH (fL)
MCHC (g/dL)
Platelets (103 /uL)
MPV (fL)
Plasma protein (g/dL)
PCV (%)
WBC’s (103 /uL)
Neutrophils (%)
Lymphocytes (%)
Monocytes (%)
Eosinophils (%)

Control male
7.95 ± 0.28
12.54 ± 0.32
38.76 ± 1.13
12.99 ± 0.30
48.73 ± 0.54
15.79 ± 0.22
32.40 ± 0.23
613.43 ± 48.41
7.67 ± 0.61
7.56 ± 0.61
38.43 ± 1.13
4.73 ± 0.56
0.89 ± 0.27
3.59 ± 0.69
0.14 ± 0.05
0.07 ± 0.05

WL aloe male
8.28 ± 0.34
12.94 ± 0.50
40.09 ± 1.33
12.89 ± 0.11
48.66 ± 0.59
15.73 ± 0.14
32.99 ± 0.37
586.57 ± 66.12
7.40 ± 0.13
12.03 ± 13.22
39.29 ± 1.60
5.17 ± 1.19
0.93 ± 0.24
3.96 ± 0.95
0.21 ± 0.11
0.06 ± 0.05

Control female
7.26 ± 0.59
12.32 ± 0.20
37.68 ± 1.21
8.10 ± 5.08
51.05 ± 0.67
16.67 ± 0.45
32.67 ± 0.58
569.17 ± 84.41
7.72 ± 0.30
6.80 ± 0.46
36.17 ± 0.98
3.42 ± 0.53
0.52 ± 0.10
2.67 ± 0.49
0.15 ± 0.05
0.03 ± 0.05

WL aloe female
6.94 ± 0.42
11.80 ± 0.71
35.83 ± 1.97
11.29 ± 0.33
51.60 ± 0.97
17.00 ± 0.77
32.94 ± 0.52
564.43 ± 61.43
7.99 ± 0.51
6.47 ± 0.69
34.71 ± 1.60
3.07 ± 1.09
0.61 ± 0.23
2.31 ± 0.90
0.13 ± 0.10
0.04 ± 0.05

All values expressed as mean ± standard deviation.
∗
𝑃 ≤ 0.05 compared with gender control.

consumption of rats fed the test extract were equivalent to the
same parameters in the control males and females (Figures 2
and 3).
One female rat died during transport from the vendor,
and thus the control group of females contained 6 rats,
while all other groups contained 7. One control female rat
developed a facial swelling during the study. This swelling
was diagnosed to be an abscessed tooth. The rat was
treated with an antibiotic (enrofloxacin) and nonsteroidal
anti-inflammatory (meloxicam) for a one-week period. This
female responded well to therapy and was included in final
data analyses.

At the study’s conclusion, weights of organs were not
significantly different from control in either sex (Table 5), and
gross necropsy was otherwise unremarkable. Hematologic
analyses showed that no parameter assessed in rats fed with
the DCWL aloe vera differed significantly from the respective
control group (Table 6). Clinical chemistry values from blood
were also generally not different from control group mice
(Table 7). There were no differences in males; however, in
females, values for albumin and cholesterol were lower in
rats fed the test extract versus control rats. Cholesterol was
reduced in males fed the test extract, but this difference was
not statistically significant.
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Table 7: The effect of aloe vera administration for 13 weeks on rat clinical chemistires.
Parameter
Glucose (mg/dL)
AST (U/L)
ALT (U/L)
ALP (U/L)
CK (U/L)
Total protein (g/dL)
Albumin (g/dL)
Globulin (g/dL)
Cholesterol (mg/dL)
BUN (mg/dL)
Creatinine (mg/dL)
Calcium (mg /dL)
Phosphorus (mg/dL)
Sodium (mmol/L)
Potassium (mmol/L)
Chloride (mmol/L)
Bicarbonate (mmol/L)
Anion gap (mmol/L)

Control male
221.0 ± 36.13
61.14 ± 14.50
35.29 ± 5.22
147.0 ± 15.77
190.43 ± 113.15
5.81 ± 0.47
3.06 ± 0.24
2.76 ± 0.26
103.7 ± 17.21
21.29 ± 2.06
0.31 ± 0.035
8.99 ± 0.69
3.89 ± 0.41
141.1 ± 1.22
3.24 ± 0.30
103.3 ± 3.15
25.00 ± 2.00
16.11 ± 1.50

WL aloe male
200.7 ± 59.92
62.33 ± 8.45
41.67 ± 13.95
152.8 ± 5.91
353.00 ± 380.35
6.02 ± 0.43
3.07 ± 0.16
2.95 ± 0.28
94.83 ± 6.85
20.17 ± 1.60
0.32 ± 0.032
9.37 ± 0.67
4.00 ± 0.44
140.7 ± 1.51
3.50 ± 0.18
101.8 ± 2.32
26.57 ± 2.70
15.77 ± 0.77

Control female
190.3 ± 8.26
71.17 ± 18.98
29.33 ± 10.29
167.17 ± 12.58
204.50 ± 72.02
5.67 ± 0.45
3.23 ± 0.27
2.42 ± 0.23
102.8 ± 9.95
17.33 ± 7.94
0.34 ± 0.02
8.25 ± 1.26
3.57 ± 0.38
140.6 ± 1.97
2.75 ± 0.14
106.2 ± 2.14
23.2 ± 3.63
13.73 ± 1.67

WL aloe female
168.9 ± 34.28
68.14 ± 12.27
25.86 ± 4.45
150.43 ± 28.81
235.29 ± 132.17
5.25 ± 0.52
2.88 ± 0.23∗
2.37 ± 0.31
84.00 ± 12.81∗
18.86 ±1.46
0.30 ± 0.03
7.46 ± 0.94
3.03 ± 0.55
142.1 ± 1.57
2.59 ± 0.20
110.6 ± 4.61
20.49 ± 2.68
13.67 ± 1.51

All values expressed as mean ± standard deviation. ∗ 𝑃 ≤ 0.05 compared with gender control.

The cecum (including the cecal-colic junction), ascending, transverse, and descending colon and rectum were
opened and examined for gross abnormalities (i.e., masses or
ulcerative lesions). No abnormalities were found in aloe or
control rats of either gender.

4. Discussion
In this study, we sought to determine if oral administration of
concentrated levels of a commercially available DCWL aloe
juice, Lily of the Desert Filtered Whole Leaf Aloe vera Juice
with Aloesorb, produced genotoxicity in vitro, acute/subacute
toxicity in mice or subchronic toxicity in rats. In agreement
with the results of others who have tested aloe vera from
the inner gel fillet [18], we found no evidence to support
genotoxic effects in bacterial assays.
In previously reported in vivo toxicity tests, aloe derivatives without the anthraquinone-containing latex are not
associated with adverse effects. Ikeno et al. [28] tested dried
powder from the inner leaf fillet in a feed study with Fischer
344 rats and found no toxicity. More recently, Tanaka et al.
[29] reported no mortalities, no abnormalities at necropsy,
and no differences in body weight gain after 14 days in a
rat study. This study tested an aloe vera gel extracted with
supercritical carbon dioxide administered as a single oral
dose of 150 mg/kg. In our in vivo assays, we also found
no evidence of aloe toxicity. In mice, our acute studies
demonstrated no mortalities, no changes in behavior, body
weight, or organ weights. Hematology and clinical chemistry
values were generally not significantly different compared to
controls although in some instances, a measured value for
one parameter was different from the control at 𝑃 ≤ 0.05.
If the mouse showed no other subjective/objective change

suggesting toxicity, we considered these values to be the
occasional outliers, which would be anticipated given the
large number of individual parameters quantitated, and we
did not feel that these were biologically relevant differences
between aloe-treated and untreated groups.
Rats fed DCWL aloe vera juice over 13 weeks also displayed no adverse signs. Necropsy evaluations, hematology,
and clinical chemistries were generally similar to the control
groups. The difference in plasma albumin was not felt to be
a toxic effect since we found no differences in total protein,
globulin, or serum protein in females and because albumin
in males fed with the test extract was not different (𝑃 = 0.94).
One notable effect was the significantly reduced cholesterol
concentration in females. Cholesterol has been reported to be
decreased in rats that were administered aloe vera previously
[30, 31]; thus, this result in our analysis is not surprising.
Huseini et al. [7] have reported that aloe gel reduced cholesterol in humans in a clinical trial; however, these clinical
results have not been verified in other studies to date. This was
a relatively short-termed study with young, healthy animals,
and this effect may have been more pronounced and/or seen
in males over a longer term or in aged animals. Studies
employing innately hypercholesterol rat models have shown
a greater cholesterol-reducing effect of aloe [32]. Natural
products that lower cholesterol are sought after by consumers
of supplements. Therefore, although this study was not one of
efficacy determination, it is a notable observation.
Of particular interest, in our 13-week rat study, there
was an analysis of the large intestine for signs of mucosal
pathology. These pathologies were reported in F344 rats
with water-administered, nondecolorized whole-leaf aloe
vera extract [10] and featured a significantly increased
incidence and severity of mucosal hyperplasia with goblet
cell hyperplasia that was more pronounced in male rats. Our
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Table 8: Consumption of Aloe vera by rats in this study versus NTP drinking water study.
Target malic acid Malic acid molarity in
Consumption of
Weight of rats at
umol/day malic acid
concentration
dosed form (mM)
dosed form (g/day)∗
4 weeks (g)∗
consumed/100 g body weight
28.80 male
200.0 male
212.8 male
NTP 1% in water
1980 (ppm)∓
14.8
22.46 female
142.6 female
232.8 female
36.2 mmol/kg
14.30 male
239.0 male
235.0 male
Present study 100 g/kg
37.8#
feed∧
9.13 female
150.0 female
229.3 female
Doses of aloe

∓

Taken from Table H4, Target values for malic acid administered to rats in the 2-year study at approximately 4 weeks, pg. 260 NTP study.
Measured in Aloe feed extract.
∗
NTP data obtained from Tables J1 and J2, pgs. 283 and 284 NTP study.
#
Assumes 1 gram feed = 1 ml solid.
∧

data obtained using a DCWL aloe vera juice contrast with
these previous results. No gross or microscopic evidence of
intestinal pathologies was observed. Rat intestinal sections
from both control and rats fed with the test extract displayed
typical mucosal phenotypes including sections with variable
levels of focal lymphoid cellularity in the lamina propria and
occasional variations in the degree of fibrous tissue between
crypts; however, crypts were uniform in length and depth and
goblet cells were evenly distributed and not over productive
with mucous secretions.
The differences in findings between our present study
and that of the NTP are most likely due to the different aloe
vera juices tested. We have not identified specific components
in nondecolorized whole-leaf aloe extract that are reduced
or absent in purified whole leaf beverages and which may
have led to the mucosal response observed by the NTP. However, attractive candidates are the anthraquinones associated
with the latex in whole leaf juice but largely absent from
activated charcoal-treated aloe. Most aloe anthraquinones
exist as glycosides, which are rarely mutagenic [33]. Free
anthraquinones, released in animals after intestinal microbial
oxidation of the glycosidic bonds, have been associated with
in vitro mutagenesis, although aloe-emodin, the predominant anthraquinone released by microbial action on aloin
glycosides, has been repeatedly found to be negative in a
variety of in vivo assays (reviewed by [31]). Longer termed
animal studies, particularly with a sensitive species, could
reveal toxicologic or carcinogenic effects not seen with acute
assays, and the rat model seems well suited to potentiate
toxic and carcinogenic effects of aloe’s anthraquinones. Rats
(as well as mice) have substantial quantities of microbial
flora throughout their upper as well as lower gastrointestinal tracts [34] including those such as Eubacterium spp.
which are capable of oxidizing the barbaloin C-glycosidic
bond [35, 36]. In contrast, humans have a relatively sterile
upper GI tract [32], and anthroid glycosides pass intact to
the colon before limited C-glycosidase activity occurs [31].
Other aloe vera components, such as polysaccharides that
serve as growth substrates for Eubacterium [37], could alter
intestinal flora in favor of glycosidase-capable bacteria. The
rat may therefore be an ideal sentinel for intestinal toxicities
associated with the phenolics in aloe; however, extrapolation
of carcinogenic outcomes should account for the degree of
relative human exposure to the free anthraquinones and the
levels of anthraquinone glycosides in the aloe juice extract
tested.

The levels of aloe vera consumed by rats in the present
study are similar to a concentration consumed by rats in
the 2-year rat NTP study (see Table 8). The NTP study
used dried nondecolorized whole leaf aloe juice powder
at levels of 0, 0.5, 1.0, and 1.5% in drinking water. At the
1.0% level, male rats in the NTP study drank an average
of 28.80 mls/day at approximately the 4-week time point.
The drinking water contained a target of 1980 ppm of malic
acid. This equates to 212.8 𝜇mol malate/day/100 g rat body
weight. Females consumed a similar amount. In our study,
males and females consumed approximately 232 𝜇mol malic
acid/day/100 g weight. These data indicate that the rats in our
study consumed an amount of aloe juice equivalent to the
1.0% aloe drinking water in the NTP study by malic acid
equivalency.
In summary, after assessing a DCWL aloe beverage for
both genetic and in vivo toxicity, we found no adverse effects
associated with high intake of aloe at acute or subchronic
periods. Importantly, we did not find hyperplastic mucosal
changes that were so notable in a recent report using nondecolorized whole-leaf aloe. Therefore, it is reasonable to believe
that components in the untreated leaf extract are responsible
for the large intestinal hyperplastic reactions at 13 weeks.
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